Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
CBC
Support for Students with Disabilities
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
Program Resources
You are here
Home
>
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions.
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.
Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.
Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.
a-Synuclein and mitochondria: partners in crime?
a-Synuclein and mitochondria: partners in crime?
Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.
Pages
1
2
next ›
last »
